NDC11 63323016226
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0162-26 | 63323-0162 |
| 63323-162-26 | 63323-162 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Fresenius Kabi USA, LLC | d1920335-8e45-4960-b6e9-e6f1f9e6820c | 2024-07-23 | Boxed warning, Warnings, Adverse reactions | 63323-162 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Fresenius Kabi USA, LLC | 950b7295-3f68-4027-ac2b-2f7d0f5f8ef9 | 2022-11-18 | Boxed warning, Warnings, Adverse reactions | 63323-162 |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Fresenius Kabi USA, LLC | ccf905ca-e164-4779-9485-2d139c821bad | 2022-09-15 | Boxed warning, Warnings, Adverse reactions | 63323-162-26 63323-162 63323016226 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.